COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,684 Articles (22,913 medRxiv, 8,771 bioRxiv)

Most recent first Previous |  Page 2629: Articles 26281-26290  | Next

Saliva-Based Molecular Testing for SARS-CoV-2 that Bypasses RNA Extraction
Ranoa, D., Holland, R., Alnaji, F. G., Green, K., Wang, L., Brooke, C., Burke, M., Fan, T., Hergenrother, P. J.
10.1101/2020.06.18.159434 — Posted: 2020-06-18 Discussion: Onsite
Sensitivity analysis of the effects of non-pharmaceutical interventions on COVID-19 in Europe
Soltesz, K., Gustafsson, F., Timpka, T., Jalden, J., Jidling, C., Heimerson, A., Schön, T., Spreco, A., Ekberg, J., Dahlström, O., Bagge Carlson, F., Jöud, A., Bernhardsson, B.
10.1101/2020.06.15.20131953 — Posted: 2020-06-18
COVID-19 PCR Test Performance For Samples Stored At Ambient Temperature
Agaoglu, N. B., Yıldız, J., Akgun Dogan, O., Alkurt, G., Kose, B., Kendir Demirkol, Y., Irvem, A., Doganay, L., Dinler-Doganay, G.
10.1101/2020.06.15.153882 — Posted: 2020-06-18
Epidemiological characteristics of patients with residual SARS-Cov-2 in Linyi, China
Pan, Q., Gao, F., Peng, R., Li, M.
10.1101/2020.06.16.20133199 — Posted: 2020-06-18 Discussion: Offsite
Time Course of COVID-19 epidemic in Algeria: Retrospective estimate of the actual burden
HAMIDOUCHE, M., BELMESSABIH, N.
10.1101/2020.06.16.20132746 — Posted: 2020-06-18
Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection
Wei, W., Ortwine, J. K., Mang, N. S., Joseph, C., Hall, B. C., Prokesch, B. C.
10.1101/2020.06.16.20133181 — Posted: 2020-06-18 Discussion: Offsite
Evaluation of specimen types and saliva stabilization solutions for SARS-CoV-2 testing
Griesemer, S. B., Van Slyke, G., Ehrbar, D., Strle, K., Yildirim, T., Centurioni, D. A., Walsh, A. C., Chang, A. K., Waxman, M. J., St. George, K.
10.1101/2020.06.16.20133041 — Posted: 2020-06-18
KNOWLEDGE AND BEHAVIORS RELATED TO THE COVID-19 PANDEMIC IN MALAWI
Banda, J., Dube, A., Brumfield, S., Amoah, A., Crampin, A., Reniers, G., Helleringer, S.
10.1101/2020.06.16.20133322 — Posted: 2020-06-18
COVID-19 outcomes, risk factors and associations by race: a comprehensive analysis using electronic health records data in Michigan Medicine
Gu, T., Mack, J. A., Salvatore, M., Sankar, S. P., Valley, T. S., Singh, K., Nallamothu, B. K., Kheterpal, S., Lisabeth, L., Fritsche, L. G., Mukherjee, B. G.
10.1101/2020.06.16.20133140 — Posted: 2020-06-18
Combined point of care nucleic acid and antibody testing for SARS-CoV-2: a prospective cohort study in suspected moderate to severe COVID-19 disease.
Mlcochova, P., Collier, D., Ritchie, A. V., Assennato, S. M., Hosmillo, M., Goel, N., Meng, B., Chatterji, K., Mendoza, V., Temperton, N., Kiss, L., Ciazyns, K. A., Xiong, X., Briggs, J. A., Nathan, J., Mescia, F., Zhang, H., Barmpounakis, P., Demeris, N., Skells, R., Lyons, P., Bradley, J., Baker, S., Lee, H. H., Smith, K. G., Goodfellow, I., Gupta, R. K.
10.1101/2020.06.16.20133157 — Posted: 2020-06-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).